Hamel Associates, Inc. Amgen Inc Transaction History
Hamel Associates, Inc.
- $315 Million
- Q2 2024
A detailed history of Hamel Associates, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Hamel Associates, Inc. holds 17,095 shares of AMGN stock, worth $5.63 Million. This represents 1.7% of its overall portfolio holdings.
Number of Shares
17,095
Previous 17,098
0.02%
Holding current value
$5.63 Million
Previous $4.86 Million
9.87%
% of portfolio
1.7%
Previous 1.56%
Shares
19 transactions
Others Institutions Holding AMGN
# of Institutions
3,049Shares Held
409MCall Options Held
7.19MPut Options Held
6.26M-
Vanguard Group Inc Valley Forge, PA51.9MShares$17.1 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$15.2 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.54 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.76 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.73 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $176B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...